NQMC Update Service: March 25, 2013 || Australian Council on Healthcare Standards

NQMC Update Service: March 25, 2013

NQMC Update Service: March 25, 2013

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 03/25/2013 12:00 PM EDT

March 25, 2013

New This Week

Measure Summaries Australian Council on Healthcare Standards Acute stroke management: percentage of inpatients with a diagnosis of ischaemic stroke receiving aspirin within 48 hours of presentation to hospital. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a diagnosis of ischaemic stroke, presenting to the hospital within 4.5 hours of stroke onset, with documented evidence that an intravenous thrombolysis agent was administered. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke who are prescribed and administered antihypertensive medication prior to discharge. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke who had a documented scan (CT or MRI) of their brain within 24 hours of presentation to hospital. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke who have documented treatment in a stroke unit at any time during their hospital stay. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke with documented evidence of a swallowing screen conducted prior to documented evidence of food or fluid intake. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke with documented physiotherapy assessment within 48 hours of presentation to hospital. This updates a previously published measure summary. Acute stroke management: percentage of inpatients with a primary diagnosis of acute stroke with evidence that a documented plan for their ongoing care in the community was developed and provided to the patient/family prior to discharge. This updates a previously published measure summary. Aged care: percentage of general medical patients 65 years and over who have a documented vitamin D deficiency who are prescribed vitamin D, during the 6 month time period. This updates a previously published measure summary. Aged care: percentage of medical patients 65 years and older who have had their cognition assessed using a validated tool such as the Abbreviated Mental Test Score (AMTS) or Mini Mental State Examination (MMSE), during the 6 month time period. This updates a previously published measure summary. Aged care: percentage of patients admitted to geriatric medicine or geriatric rehabilitation unit for whom there is documented objective assessment of physical function on admission and at least once more during the inpatient stay, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of inpatients undergoing coronary artery bypass graft (CABG) within 24 hours of percutaneous transluminal coronary angioplasty (PCTA) (with or without stenting) in the same admission, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) and atrial fibrillation (AF) who have no contraindication to the use of warfarin, who are prescribed warfarin, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) who have no contraindications to the use of an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (A2RA) who are prescribed an ACEI or A2RA, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) who have no contraindications to the use of beta-blockers and who are prescribed beta-blocker therapy, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of patients discharged with any diagnosis of congestive heart failure (CHF) who are referred for chronic disease management service that includes physical rehabilitation, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of patients with acute myocardial infarction (AMI) requiring thrombolysis who receive thrombolytic therapy within 1 hour of presentation to the hospital, during the 6 month time period. This updates a previously published measure summary. Cardiovascular disease: percentage of vessels in which percutaneous transluminal coronary angioplasty (PTCA) (with or without stenting) is undertaken where primary success, as defined, is achieved, during the 6 month time period. This updates a previously published measure summary. Endocrine disease: percentage of insulin treated diabetic inpatients having an elective operation, and a length of stay greater than or equal to 48 hours, whose medical record shows at least 4 blood glucose measurements on the first post-operative day, during the 6 month time period. This updates a previously published measure summary. Endocrine disease: percentage of insulin treated diabetic inpatients having an elective operation, and a length of stay greater than or equal to 48 hours, with a recorded blood glucose level less than 4 mmol/L in the post-operative period, during the 6 month time period. This updates a previously published measure summary. Endocrine disease: percentage of patients admitted with diabetes having assessment of lower limbs according to guidelines, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion and endoscopic therapy who subsequently have an operation during the same admission, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion and have a gastroscopy within 24 hours of admission, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion and have an operation during the same admission, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion and subsequently die, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion who are discharged with a specific diagnosis that explains the cause of bleeding, during the 6 month time period. This updates a previously published measure summary. Gastrointestinal disease: percentage of patients admitted to hospital with haematemesis and/or melaena who receive a blood transfusion, for which there is documented evidence that a member of the surgical staff has been notified of their condition, during the 6 month time period. This updates a previously published measure summary. Oncology: percentage of pre-menopausal patients with stage II carcinoma of the breast for whom there is documented evidence of treatment, or intention to treat, with poly-chemotherapy, during the 6 month time period. This updates a previously published measure summary. Renal disease: percentage of inpatients having a renal biopsy who subsequently develop macroscopic haematuria in any of their voided urine specimens within 24 hours of the procedure, during the 6 month time period. This updates a previously published measure summary. Respiratory disease: percentage of patients admitted to hospital with a diagnosis of acute asthma for whom there is documented evidence of an appropriate discharge plan, during the 6 month time period. This updates a previously published measure summary. Respiratory disease: percentage of patients admitted to hospital with a diagnosis of acute asthma for whom there is documented objective assessment of severity in addition to the initial assessment, which facilitates ongoing inpatient management, during the 6 month time period. This updates a previously published measure summary. Respiratory disease: percentage of patients admitted to hospital with a diagnosis of acute asthma for whom there is documented objective assessment of severity on initial presentation, during the 6 month time period. This updates a previously published measure summary. Respiratory disease: percentage of patients discharged from a general medical unit with any diagnosis of chronic obstructive pulmonary disease (COPD) who are referred for a chronic disease management service that includes physical rehabilitation, during the 6 month time period. This updates a previously published measure summary.